1-deoxynojirimycin has been researched along with Diabetic Nephropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, A; Araki, S; Haneda, M; Itoh, H; Koya, D; Maegawa, H; Nakagawa, A; Nishizawa, M; Uzu, T; Yokomaku, Y; Yokoyama, H | 1 |
| Reuser, AJ; Wisselaar, HA | 1 |
| Bischoff, H | 1 |
2 review(s) available for 1-deoxynojirimycin and Diabetic Nephropathies
| Article | Year |
|---|---|
An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Animals; Blood Glucose; Carbohydrate Sequence; Contraindications; Diabetes Mellitus; Diabetic Nephropathies; Glucosamine; Glycogen; Glycogen Storage Disease; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Molecular Sequence Data; Sucrase-Isomaltase Complex; Trisaccharides | 1994 |
Pharmacology of alpha-glucosidase inhibition.
Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Carbohydrate Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Neuropathies; Dietary Carbohydrates; Digestion; Glucosamine; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Molecular Sequence Data; Trisaccharides | 1994 |
1 other study(ies) available for 1-deoxynojirimycin and Diabetic Nephropathies
| Article | Year |
|---|---|
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.
Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Interleukin-18; Postprandial Period | 2011 |